Angiogenesis imaging in Neoplasia

Journal of Clinical Imaging Science

Volumn 1, Issue 1, 2011, Pages

  Bowden, David ^a   Barrett, Tristan ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Angiogenesis; dynamic contrast enhanced magnetic resonance imaging; molecular imaging; positron emission tomography

Indexed keywords

EID: 84869187722     PISSN: None     EISSN: 21565597     Source Type: Journal    
DOI: 10.4103/2156-7514.83229     Document Type: Article

References (17)

1. Folkman J. Tumor angiogenesis: Therapeutic implications. N Engl J Med 1971;285:1182-6.
2. The Angiogenesis Foundation, Cambridge MA. Available from: http://www.angio.org/providers/oncology/fda-approved-therapies.html. [Last accessed on 2011 Apr 15].
3. Folkman J. New perspectives in clinical oncology from angiogenesis research. Eur J Cancer 1996;32A:2534-9.
4. Hashizume H, Baluk P, Morikawa S, McLean JW, Thurston G, Roberge S, et al. Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol 2000;156:1363-80. (Pubitemid 30660013)
5. Barrett T, Bernardo M, Brechbiel M, Choyke P. MRI of tumor angiogenesis. J Magn Reson Imaging 2007;26:235-49. (Pubitemid 47257720)
6. Kuhl CK, Mielcareck P, Klaschik S, Leutner C, Wardelmann E, Gieseke J, et al. Dynamic breast MRI: Are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology 1999;211:101-10. (Pubitemid 29161739)
7. Figg W, Folkman J. Angiogenesis: An integrative approach from science to medicine. Boston Springer; 2008. p. 322-33. Refer 90 http://ccr.ncifcrf.gov/ Staff/publications.asp?profileid=5728&display=all.
8. O′Connor JP, Jackson A, Parker GJ, Jayson GC. DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents. Br J Cancer 2007;96:189-95. (Pubitemid 46160619)
9. Zhong L, Wang WJ, Xu J. Clinical application of hepatic CT perfusion. World J Gastroenterol 2009;15:907-11.
10. Sahani DV, Holalkere NS, Mueller PR, Zhu AX. Advanced HCC: CT perfusion of liver and tumor tissue-Initial experience. Radiology 2007;243:736-43. (Pubitemid 46799427)
11. Cosgrove D. Angiogenesis imaging-ultrasound. Br J Radiol 2003;76:S43-9.
12. Haubner R, Weber WA, Beer AJ, Vabuliene E, Reim D, Sarbia M, et al. Noninvasive visualization of v3 integrin in cancer patients by PET and [18F]Galacto-RGD. PLoS Med 2005;2:e70.
13. Arbab AS, Janic B, Knight RA, Anderson SA, Pawelczyk E, Rad AM, et al. Detection of migration of locally implanted AC 133+ stem cells by cellular magnetic resonance imaging with histological findings. FASEB J 2008;22:3234-46.
14. Jiang T, Kambadakone A, Kulkarni NM, Zhu AX, Sahani DV. Monitoring response to antiangiogenic treatment and predicting outcomes in advanced hepatocellular carcinoma using image biomarkers, CT perfusion, tumor density, and tumor size (RECIST). Invest Radiol 2011 May 13.(Epub ahead of print) refer pubmed http://www.ncbi.nlm.nih.gov/pubmed/21512396.
15. Fournier LS, Oudard S, Thiam R, Trinquart L, Banu E, Medioni J, et al. Metastatic renal carcinoma: Evaluation of antiangiogenic therapy with dynamic contrast-enhanced CT. Radiology 2010;256:511-8.
16. Akisik MF, Sandrasegaran K, Bu G, Lin C, Hutchins GD, Chiorean EG. Pancreatic cancer: Utility of dynamic contrast-enhanced MR imaging in assessment of antiangiogenic therapy. Radiology 2010;256:441-9.
17. de Langen AJ, van den Boogaart V, Lubberink M, Backes WH, Marcus JT, van Tinteren H, et al. Monitoring response to antiangiogenic therapy in non-small cell lung cancer using imaging markers derived from PET and dynamic contrast-enhanced MRI. J Nucl Med 2011;52:48-55.